Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

CRISPR Therapeutics (CRSP) has been making waves lately, especially after announcing promising early clinical data for its ...

A study using CRISPR restored brain connectivity and made the brain more resilient to seizures, which are often seen in a ...

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...